344 related articles for article (PubMed ID: 15615865)
1. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors.
Uberti MA; Hague C; Oller H; Minneman KP; Hall RA
J Pharmacol Exp Ther; 2005 Apr; 313(1):16-23. PubMed ID: 15615865
[TBL] [Abstract][Full Text] [Related]
2. Alpha2C-adrenergic receptors exhibit enhanced surface expression and signaling upon association with beta2-adrenergic receptors.
Prinster SC; Holmqvist TG; Hall RA
J Pharmacol Exp Ther; 2006 Sep; 318(3):974-81. PubMed ID: 16757535
[TBL] [Abstract][Full Text] [Related]
3. Functional alpha1- and beta2-adrenergic receptors in human osteoblasts.
Huang HH; Brennan TC; Muir MM; Mason RS
J Cell Physiol; 2009 Jul; 220(1):267-75. PubMed ID: 19334040
[TBL] [Abstract][Full Text] [Related]
4. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties.
Uberti MA; Hall RA; Minneman KP
Mol Pharmacol; 2003 Dec; 64(6):1379-90. PubMed ID: 14645668
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in alpha1-adrenergic receptor research.
Chen ZJ; Minneman KP
Acta Pharmacol Sin; 2005 Nov; 26(11):1281-7. PubMed ID: 16225747
[TBL] [Abstract][Full Text] [Related]
6. Internalization and distribution of three alpha1-adrenoceptor subtypes in HEK293A cells before and after agonist stimulation.
Wang SY; Song Y; Xu M; He QH; Han QD; Zhang YY
Acta Pharmacol Sin; 2007 Mar; 28(3):359-66. PubMed ID: 17302998
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors.
Koshimizu TA; Tsujimoto G; Hirasawa A; Kitagawa Y; Tanoue A
Cardiovasc Res; 2004 Sep; 63(4):662-72. PubMed ID: 15306222
[TBL] [Abstract][Full Text] [Related]
8. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP
Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745
[TBL] [Abstract][Full Text] [Related]
9. Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity.
Hague C; Lee SE; Chen Z; Prinster SC; Hall RA; Minneman KP
Mol Pharmacol; 2006 Jan; 69(1):45-55. PubMed ID: 16195468
[TBL] [Abstract][Full Text] [Related]
10. Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation.
Hosoda C; Koshimizu TA; Tanoue A; Nasa Y; Oikawa R; Tomabechi T; Fukuda S; Shinoura H; Oshikawa S; Takeo S; Kitamura T; Cotecchia S; Tsujimoto G
Mol Pharmacol; 2005 Mar; 67(3):912-22. PubMed ID: 15598970
[TBL] [Abstract][Full Text] [Related]
11. Expression of alpha-adrenoceptor subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture.
Faber JE; Yang N; Xin X
J Pharmacol Exp Ther; 2001 Aug; 298(2):441-52. PubMed ID: 11454904
[TBL] [Abstract][Full Text] [Related]
12. Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors.
Hague C; Uberti MA; Chen Z; Hall RA; Minneman KP
J Biol Chem; 2004 Apr; 279(15):15541-9. PubMed ID: 14736874
[TBL] [Abstract][Full Text] [Related]
13. Role of adrenergic receptor subtypes in the control of human placental blood vessels.
Resch BE; Ducza E; Gáspár R; Falkay G
Mol Reprod Dev; 2003 Oct; 66(2):166-71. PubMed ID: 12950104
[TBL] [Abstract][Full Text] [Related]
14. The N terminus of the human alpha1D-adrenergic receptor prevents cell surface expression.
Hague C; Chen Z; Pupo AS; Schulte NA; Toews ML; Minneman KP
J Pharmacol Exp Ther; 2004 Apr; 309(1):388-97. PubMed ID: 14718583
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation on human skin fibroblast by alpha1 adrenergic receptor subtypes.
Sterin-Borda L; Furlan C; Orman B; Borda E
Biochem Pharmacol; 2007 Nov; 74(9):1401-12. PubMed ID: 17714696
[TBL] [Abstract][Full Text] [Related]
16. Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
Rousseau G; Nantel F; Bouvier M
Mol Pharmacol; 1996 Apr; 49(4):752-60. PubMed ID: 8609905
[TBL] [Abstract][Full Text] [Related]
17. Novel alpha1-adrenergic receptor signaling pathways: secreted factors and interactions with the extracellular matrix.
Shi T; Duan ZH; Papay R; Pluskota E; Gaivin RJ; de la Motte CA; Plow EF; Perez DM
Mol Pharmacol; 2006 Jul; 70(1):129-42. PubMed ID: 16617165
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus.
Hillman KL; Doze VA; Porter JE
J Pharmacol Exp Ther; 2005 Aug; 314(2):561-7. PubMed ID: 15908513
[TBL] [Abstract][Full Text] [Related]
19. Enhanced vascular contractility in alpha1-adrenergic receptor-deficient mice.
Sanbe A; Tanaka Y; Fujiwara Y; Miyauchi N; Mizutani R; Yamauchi J; Cotecchia S; Koike K; Tsujimoto G; Tanoue A
Life Sci; 2009 May; 84(21-22):713-8. PubMed ID: 19249315
[TBL] [Abstract][Full Text] [Related]
20. Alpha1-adrenoreceptor in human hippocampus: binding and receptor subtype mRNA expression.
Szot P; White SS; Greenup JL; Leverenz JB; Peskind ER; Raskind MA
Brain Res Mol Brain Res; 2005 Oct; 139(2):367-71. PubMed ID: 16039007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
